N4 Pharma PLC Holding(s) in Company (4349V)
03 November 2017 - 1:31AM
UK Regulatory
TIDMN4P
RNS Number : 4349V
N4 Pharma PLC
02 November 2017
TR-1: Standard form for notification of major holdings
1a. Identity of the issuer N4 PHARMA PLC
or the underlying issuer
of existing shares to which
voting rights are attached(ii)
:
------------------------------------------------- -------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
----------------------------------------------------------------------------------------------------
Non-UK issuer
------------------------------------------------------------------------------------- -------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------------------------- -------------
An acquisition or disposal of financial instruments
------------------------------------------------------------------------------------- -------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------- -------------
Other (please specify)(iii) :
------------------------------------------------------------------------------------- -------------
3. Details of person subject to the notification obligation(iv)
Name MYLES MCNULTY
City and country of registered
office (if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
----------------------------------------------------------------------------------------------------
Name
------------------------------------------------- -------------------------------------------------
City and country of registered
office (if applicable)
------------------------------------------------- -------------------------------------------------
5. Date on which the threshold 02 November 2017
was crossed or reached(vi)
:
------------------------------------------------- -------------------------------------------------
6. Date on which issuer notified 02 November 2017
(DD/MM/YYYY):
------------------------------------------------- -------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
----------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer(vii)
8. A) (total of
8.B 1 + 8.B
2)
---------------------- ------------------------- ---------------- ---------------- -------------
Resulting
situation
on the date
on which
threshold
was crossed
or reached 3.01% 3.01% 74,714,285
---------------------- ------------------------- ---------------- ---------------- -------------
Position NA NA
of previous
notification
(if
applicable)
---------------------- ------------------------- ---------------- ---------------- -------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
------------------------------------------------------------------------------------------------------
Class/type Number of voting rights(ix) % of voting rights
of
shares
ISIN code
(if possible)
-----------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10 of
Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
---------------- --------------- -------------- ---------------------------------- --------------
CA60686A4090 2,250,000 3.01%
----------------- --------------- -------------- ---------------------------------- --------------
SUBTOTAL
8. A 2,250,000 3.01%
----------------- ------------------------------- --------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date(x) Conversion rights that rights
instrument Period(xi) may be acquired
if the instrument
is
exercised/converted.
----------------- --------------- -------------- ---------------------------------- --------------
Warrant 350,000 0.47%
----------------- --------------- -------------- ---------------------------------- --------------
SUBTOTAL 8.
B 1 350,000 0.47%
-------------- ---------------------------------- --------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date(x) Conversion or cash of voting rights
instrument Period settlement(xii) rights
(xi)
---------------- ---------------- -------------- ---------------- ---------------- --------------
SUBTOTAL
8.B.2
---------------- ---------------- --------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is X
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity(xiv) (please add additional rows as
necessary)
-------------------------------------------------------------------------------------- --------------
Name(xv) % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial or is higher
higher than instruments than the notifiable
the notifiable if it equals threshold
threshold or is higher
than the
notifiable
threshold
----------------- ------------------------------- ---------------- --------------------------------
10. In case of proxy voting, please identify:
------------------------------------------------------------------------------------------------------
Name of the proxy holder
-------------------------------------------------- --------------------------------------------------
The number and % of voting
rights held
-------------------------------------------------- --------------------------------------------------
The date until which the
voting rights will be held
-------------------------------------------------- --------------------------------------------------
11. Additional information(xvi)
------------------------------------------------------------------------------------------------------
Place of completion London
-------------------- -----------------
Date of completion 02 November 2017
-------------------- -----------------
The company news service from the London Stock Exchange
END
HOLLLFVSLILFIID
(END) Dow Jones Newswires
November 02, 2017 10:31 ET (14:31 GMT)
N4 Pharma (LSE:N4P)
Historical Stock Chart
From Apr 2024 to May 2024
N4 Pharma (LSE:N4P)
Historical Stock Chart
From May 2023 to May 2024